17 alpha-hydroxyprogesterone caproate has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GELLER, J; LEWIN, M; VOLK, H | 1 |
| CROWLEY, LG; MACDONALD, I | 1 |
| Iglódi, F | 1 |
3 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Breast Neoplasms
| Article | Year |
|---|---|
Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Breast; Breast Neoplasms; Caproates; Humans; Hydroxyprogesterones; Progesterone | 1961 |
DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Breast Neoplasms; Diethylstilbestrol; Drug Therapy; Estradiol; Estrogens; Female; Geriatrics; Humans; Hydroxyprogesterones; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Pathology; Postmenopause | 1965 |
Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents; Breast Neoplasms; Cell Differentiation; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Menopause; Tamoxifen; Testosterone; Vaginal Smears | 1989 |